BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19610065)

  • 1. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
    Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
    Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal anti-apoptotic androgen receptor target gene c-FLIP in prostate cancer.
    Ye H; Li Y; Melamed J; Pearce P; Wei J; Chiriboga L; Wang Z; Osman I; Lee P
    J Urol; 2009 Feb; 181(2):872-7. PubMed ID: 19095249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion.
    Li Y; Wang L; Zhang M; Melamed J; Liu X; Reiter R; Wei J; Peng Y; Zou X; Pellicer A; Garabedian MJ; Ferrari A; Lee P
    Cancer Res; 2009 Apr; 69(8):3332-8. PubMed ID: 19351848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of mir-146a function in hormone-refractory prostate cancer.
    Lin SL; Chiang A; Chang D; Ying SY
    RNA; 2008 Mar; 14(3):417-24. PubMed ID: 18174313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Oncogenic Transcription Factor Cooperation in RB-Deficient Cancer.
    Mandigo AC; Shafi AA; McCann JJ; Yuan W; Laufer TS; Bogdan D; Gallagher L; Dylgjeri E; Semenova G; Vasilevskaya IA; Schiewer MJ; McNair CM; de Bono JS; Knudsen KE
    Cancer Res; 2022 Jan; 82(2):221-234. PubMed ID: 34625422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines.
    Mad'arová J; Lukesová M; Hlobilková A; Strnad M; Vojtesek B; Lenobel R; Hajdúch M; Murray PG; Perera S; Kolár Z
    Mol Pathol; 2002 Aug; 55(4):227-34. PubMed ID: 12147712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ID4 promotes AR expression and blocks tumorigenicity of PC3 prostate cancer cells.
    Komaragiri SK; Bostanthirige DH; Morton DJ; Patel D; Joshi J; Upadhyay S; Chaudhary J
    Biochem Biophys Res Commun; 2016 Sep; 478(1):60-66. PubMed ID: 27462022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic comparison of prostate cancer cell lines LNCaP-FGC and LNCaP-r reveals heatshock protein 60 as a marker for prostate malignancy.
    Johansson B; Pourian MR; Chuan YC; Byman I; Bergh A; Pang ST; Norstedt G; Bergman T; Pousette A
    Prostate; 2006 Sep; 66(12):1235-44. PubMed ID: 16705742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.
    Marques RB; Dits NF; Erkens-Schulze S; van Weerden WM; Jenster G
    PLoS One; 2010 Oct; 5(10):e13500. PubMed ID: 20976069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prohibitin Links Cell Cycle, Motility and Invasion in Prostate Cancer Cells.
    Koushyar S; Uysal-Onganer P; Jiang WG; Dart DA
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANX7, a candidate tumor suppressor gene for prostate cancer.
    Srivastava M; Bubendorf L; Srikantan V; Fossom L; Nolan L; Glasman M; Leighton X; Fehrle W; Pittaluga S; Raffeld M; Koivisto P; Willi N; Gasser TC; Kononen J; Sauter G; Kallioniemi OP; Srivastava S; Pollard HB
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4575-80. PubMed ID: 11287641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Molecular Biomarkers Associated with the Progression of Prostate Cancer.
    Martin-Caraballo M
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human SP-D Acts as an Innate Immune Surveillance Molecule Against Androgen-Responsive and Androgen-Resistant Prostate Cancer Cells.
    Thakur G; Prakash G; Murthy V; Sable N; Menon S; Alrokayan SH; Khan HA; Murugaiah V; Bakshi G; Kishore U; Madan T
    Front Oncol; 2019; 9():565. PubMed ID: 31355132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.
    Kumar A; Coleman I; Morrissey C; Zhang X; True LD; Gulati R; Etzioni R; Bolouri H; Montgomery B; White T; Lucas JM; Brown LG; Dumpit RF; DeSarkar N; Higano C; Yu EY; Coleman R; Schultz N; Fang M; Lange PH; Shendure J; Vessella RL; Nelson PS
    Nat Med; 2016 Apr; 22(4):369-78. PubMed ID: 26928463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin A7 and Its Related Protein Suppressor of Death Domains Regulates Migration and Proliferation of Hca-P Cells.
    Wang S; Bai Q; Yu X; Gao F; Sun Y; Wang X
    Cell J; 2023 Nov; 25(11):801-808. PubMed ID: 38071412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rbf/E2F1 control growth and endoreplication via steroid-independent Ecdysone Receptor signalling in Drosophila prostate-like secondary cells.
    Sekar A; Leiblich A; Wainwright SM; Mendes CC; Sarma D; Hellberg JEEU; Gandy C; Goberdhan DCI; Hamdy FC; Wilson C
    PLoS Genet; 2023 Jun; 19(6):e1010815. PubMed ID: 37363926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of annexin A7 suppresses senescence-associated heterochromatin foci formation and senescence through the AMPK/mTOR pathway in human dermal fibroblasts.
    Li N; Yan X; Cui X; Zhao C; Lin Z; Miao J
    J Cell Biochem; 2023 Oct; 124(10):1603-1614. PubMed ID: 37682859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling a lethal prostate cancer variant with small-cell carcinoma features.
    Tzelepi V; Zhang J; Lu JF; Kleb B; Wu G; Wan X; Hoang A; Efstathiou E; Sircar K; Navone NM; Troncoso P; Liang S; Logothetis CJ; Maity SN; Aparicio AM
    Clin Cancer Res; 2012 Feb; 18(3):666-77. PubMed ID: 22156612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma reduces cell surface expression of annexin 2 and suppresses the invasive capacity of prostate cancer cells.
    Hastie C; Masters JR; Moss SE; Naaby-Hansen S
    J Biol Chem; 2008 May; 283(18):12595-603. PubMed ID: 18211896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplex profiling identifies clinically relevant signalling proteins in an isogenic prostate cancer model of radioresistance.
    Inder S; Bates M; Ni Labhrai N; McDermott N; Schneider J; Erdmann G; Jamerson T; Belle VA; Prina-Mello A; Thirion P; Manecksha PR; Cormican D; Finn S; Lynch T; Marignol L
    Sci Rep; 2019 Nov; 9(1):17325. PubMed ID: 31758038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.